SI
Scharf Investments Portfolio holdings
AUM
$3.47B
This Quarter Return
-1.48%
1 Year Return
+21.7%
3 Year Return
+65.93%
5 Year Return
+131.37%
10 Year Return
+271.01%
AUM
$3.17B
AUM Growth
+$3.17B
(-3.8%)
Cap. Flow
-$65.9M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
56.23%
Holding
51
New
2
Increased
22
Reduced
22
Closed
3
Top Buys
| 1 |
AstraZeneca
AZN
|
$58M |
| 2 |
Fiserv
FI
|
$40.8M |
| 3 |
Valvoline
VVV
|
$17M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$15.5M |
| 5 |
MillerKnoll
MLKN
|
$9.42M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$84.1M |
| 2 |
Quest Diagnostics
DGX
|
$39.7M |
| 3 |
Microsoft
MSFT
|
$29M |
| 4 |
Oracle
ORCL
|
$19.7M |
| 5 |
KSU
Kansas City Southern
KSU
|
$6.97M |
Sector Composition
| 1 | Healthcare | 24.87% |
| 2 | Technology | 21.44% |
| 3 | Financials | 14.59% |
| 4 | Consumer Discretionary | 12.14% |
| 5 | Communication Services | 12.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $267M | 8.43% | 946,937 -102,855 | -10% | -$29M |
|
2
Berkshire Hathaway Class B
BRK.B
$1.09T
| $213M | 6.73% | 781,304 -7,926 | -1% | -$2.16M |
|
3
Advance Auto Parts
AAP
$3.66B
| $178M | 5.6% | 850,066 -8,214 | -1% | -$1.72M |
|
4
Comcast
CMCSA
$125B
| $177M | 5.59% | 3,170,457 -52,136 | -2% | -$2.91M |
|
5
McKesson
MCK
$85.4B
| $174M | 5.48% | 871,579 +6,171 | +0.7% | +$1.23M |
|
6
CVS Health
CVS
$92.8B
| $169M | 5.32% | 1,987,330 -14,794 | -0.7% | -$1.26M |
|
|
7
Oracle
ORCL
$635B
| $166M | 5.25% | 1,908,245 -226,524 | -11% | -$19.7M |
|
8
Markel Group
MKL
$24.8B
| $154M | 4.86% | 128,692 -1,170 | -0.9% | -$1.4M |
|
9
Liberty Broadband Class C
LBRDK
$8.73B
| $143M | 4.52% | 829,642 -9,395 | -1% | -$1.62M |
|
|
10
Valvoline
VVV
$4.93B
| $141M | 4.45% | 4,518,560 +544,139 | +14% | +$17M |
|
11
Centene
CNC
$14.3B
| $127M | 3.99% | 2,030,913 -39,824 | -2% | -$2.48M |
|
|
12
Fiserv
FI
$75.1B
| $126M | 3.99% | 1,165,563 +376,199 | +48% | +$40.8M |
|
13
Masco
MAS
$15.4B
| $126M | 3.98% | 2,270,024 -66,094 | -3% | -$3.67M |
|
14
Lockheed Martin
LMT
$106B
| $123M | 3.9% | 357,725 -11,854 | -3% | -$4.09M |
|
15
Johnson & Johnson
JNJ
$427B
| $121M | 3.8% | 746,555 -18,668 | -2% | -$3.01M |
|
16
Cognizant
CTSH
$35.3B
| $109M | 3.45% | 1,471,555 -15,602 | -1% | -$1.16M |
|
17
Novartis
NVS
$245B
| $102M | 3.21% | 1,244,711 -17,882 | -1% | -$1.46M |
|
18
Unilever
UL
$155B
| $95.7M | 3.02% | 1,764,666 -19,289 | -1% | -$1.05M |
|
19
Progressive
PGR
$145B
| $90.1M | 2.84% | 996,950 -9,163 | -0.9% | -$828K |
|
|
20
MillerKnoll
MLKN
$1.43B
| $60.8M | 1.92% | 1,613,908 +250,078 | +18% | +$9.42M |
|
|
21
AstraZeneca
AZN
$248B
| $58M | 1.83% | +966,030 | New | +$58M |
|
|
KSU
22
DELISTED
Kansas City Southern
KSU
| $56.4M | 1.78% | 208,412 -25,730 | -11% | -$6.97M |
|
23
Baidu
BIDU
$32.8B
| $55.5M | 1.75% | 360,829 -10,092 | -3% | -$1.55M |
|
24
Jacobs Solutions
J
$17.5B
| $51.6M | 1.63% | 389,286 -8,753 | -2% | -$1.16M |
|
|
25
Quest Diagnostics
DGX
$20.3B
| $35M | 1.1% | 240,648 -273,105 | -53% | -$39.7M |
|